Colorectal Oncology Research Review, Issue 21

In this issue:
Poorer survival with metabolic syndrome
Mediterranean diet reduces CRC risk
Missed opportunities for earlier diagnosis of CRC
Symptoms and time to diagnosis of CRC
Predictors of fatigue in CRC
FOLFIRI plus cetuximab for RAS wild-type metastatic CRC
DNA mismatch repair deficiency in rectal cancer
Prognostic marker validated in stage II colon cancer
Older CRC patients and combination chemotherapy
Neoadjuvant chemoradiotherapy for rectal cancer

Please login below to download this issue (PDF)

Subscribe